On December 9, the US Preventive Services Task Force (USPSTF) published updated recommendations on the screening of abdominal aortic aneurysm (AAA) based on patient's gender, age, history of smoking, and family history of AAA for symptomatic adults:
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Abdominal Aorta
December 11, 2019
November 7, 2019
Interesting retrospective imaging study of true and false lumens with or without bare metal stents placed distally in the abdominal aorta.
June 2, 2019
The NEJM published the long-term results of the OVER study of open repair (OR) versus endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm (AAA) on May 30.
February 19, 2019
This review summarizes the current understanding of the inherited basis for aortic aneurysmal disease and clearly highlights the need to differentiate between thoracic and abdominal aortic manifestations.
February 13, 2019
In this paper, Dr Coselli and colleagues analyzed their experience with spinal cord deficit (SCD) after 1114 extent II open thoracoabdominal aortic aneurysm repairs performed from 1991-2017.
February 8, 2019
The European Journal of Vascular and Endovascular Surgery published The European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aortoiliac artery aneurysms.
January 22, 2019
The medical therapies for thoracic aortic aneurysm comprise of β-adrenergic blocking agents and angiotensin II type I receptor.
January 3, 2019
On December 20, 2018, the US Food and Drug Administration (FDA) issued a new warning against the use of fluoroquinolones in patients with connective tissue disorders and those predisposed to aortic disease.
November 26, 2018
The authors compared the early and long-term survival in 9165 patients undergoing medical therapy (95%), open repair (2%), and thoracic endovascular aortic repair (TEVAR, 2.9%) for uncomplicated acute type B dissection. One- and 5-year survivals were 84% and 60% for medical therapy, 76% and 67% for open repair, and 85% and 76% for TEVAR (log-rank, P
June 29, 2018
Patient Care and General Interest